Halyard Health, Inc. (NYSE:HYH) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

As previously disclosed, on July 31, 2017, Halyard Health, Inc. (the “Company”) entered into a Retention Incentive Agreement with Christopher M. Lowery, the Company’s Chief Operating Officer (“COO”), to secure Mr. Lowery’s services during a CEO transition period that was expected to end on or before December 15, 2017. The CEO transition has been successfully completed and, as of December 1, 2017, Mr. Lowery will no longer have the duties and responsibilities associated with being the Company’s COO. Mr. Lowery will remain employed by the Company until December 31, 2017, as he oversees the transfer of his current duties to others.

About Halyard Health, Inc. (NYSE:HYH)

Halyard Health, Inc. seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. The S&IP segment’s product portfolio includes sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves. The S&IP segment is also a provider of education to prevent healthcare-associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. Its products include QUICK CHECK, SMART-FOLD, POWERGUARD, MICROCOOL and FLUIDSHIELD.